|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/26 | (2006.01) |
| C07K 16/26 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/507 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K2039/505 | (2013.01) |
| (11) | Number of the document | 3720879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18829742.8 |
| Date of filing the European patent application | 2018-12-05 | |
| (97) | Date of publication of the European application | 2020-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/083651 |
| Date | 2018-12-05 |
| (87) | Number | WO 2019/110662 |
| Date | 2019-06-13 |
| (30) | Number | Date | Country code |
| 201762594755 P | 2017-12-05 | US |
| (72) |
PRIEUR, Alexandre , FR
|
| (73) |
Progastrine et Cancers S.à r.l. ,
11, Côte d'Eich, 1450 Luxembourg,
LU
|
| (54) | COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER |
| COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER |